Innovative approach for self-management and social welfare of children with cystic fibrosis in Europe: Development, validation and implementation of an mHealth tool (MyCyFAPP)

Joaquim Calvo-Lerma, Celia P. Martinez-Jimenez, Juan Pablo Lázaro-Ramos, Ana Andrés, Paula Crespo-Escobar, Erlend Stav, Cornelia Schauber, Lucia Pannese, Jessie M. Hulst, Lucrecia Suárez, Carla Colombo, Celeste Barreto, Kris De Boeck, Carmen Ribes-Koninckx

Research output: Contribution to journalArticle

Abstract

Introduction: For the optimal management of children with cystic fibrosis, there are currently no efficient tools for the precise adjustment of pancreatic enzyme replacement therapy, either for advice on appropriate dietary intake or for achieving an optimal nutrition status. Therefore, we aim to develop a mobile application that ensures a successful nutritional therapy in children with cystic fibrosis. Methods and analysis: A multidisciplinary team of 12 partners coordinate their efforts in 9 work packages that cover the entire so-called 'from laboratory to market' approach by means of an original and innovative co-design process. A cohort of 200 patients with cystic fibrosis aged 1-17 years are enrolled. We will develop an innovative, clinically tested mobile health application for patients and health professionals involved in cystic fibrosis management. The mobile application integrates the research knowledge and innovative tools for maximising self-management with the aim of leading to a better nutritional status, quality of life and disease prognosis. Bringing together different and complementary areas of knowledge is fundamental for tackling complex challenges in disease treatment, such as optimal nutrition and pancreatic enzyme replacement therapy in cystic fibrosis. Patients are expected to benefit the most from the outcomes of this innovative project. Ethics and dissemination: The project is approved by the Ethics Committee of the coordinating organisation, Hospital Universitari La Fe (Ref: 2014/ 0484). Scientific findings will be disseminated via journals and conferences addressed to clinicians, food scientists, information and communications technology experts and patients. The specific dissemination working group within the project will address the wide audience communication through the website (http://www.mycyfapp.eu), the social networks and the newsletter.

Original languageEnglish
Article numbere014931
JournalBMJ Open
Volume7
Issue number3
DOIs
Publication statusPublished - Mar 1 2017

Fingerprint

Telemedicine
Social Welfare
Self Care
Cystic Fibrosis
Mobile Applications
Enzyme Replacement Therapy
Nutritional Status
Communication
Social Adjustment
Ethics Committees
Ethics
Social Support
Quality of Life
Organizations
Technology
Food
Health
Therapeutics
Research

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Calvo-Lerma, J., Martinez-Jimenez, C. P., Lázaro-Ramos, J. P., Andrés, A., Crespo-Escobar, P., Stav, E., ... Ribes-Koninckx, C. (2017). Innovative approach for self-management and social welfare of children with cystic fibrosis in Europe: Development, validation and implementation of an mHealth tool (MyCyFAPP). BMJ Open, 7(3), [e014931]. https://doi.org/10.1136/bmjopen-2016-014931

Innovative approach for self-management and social welfare of children with cystic fibrosis in Europe : Development, validation and implementation of an mHealth tool (MyCyFAPP). / Calvo-Lerma, Joaquim; Martinez-Jimenez, Celia P.; Lázaro-Ramos, Juan Pablo; Andrés, Ana; Crespo-Escobar, Paula; Stav, Erlend; Schauber, Cornelia; Pannese, Lucia; Hulst, Jessie M.; Suárez, Lucrecia; Colombo, Carla; Barreto, Celeste; De Boeck, Kris; Ribes-Koninckx, Carmen.

In: BMJ Open, Vol. 7, No. 3, e014931, 01.03.2017.

Research output: Contribution to journalArticle

Calvo-Lerma, J, Martinez-Jimenez, CP, Lázaro-Ramos, JP, Andrés, A, Crespo-Escobar, P, Stav, E, Schauber, C, Pannese, L, Hulst, JM, Suárez, L, Colombo, C, Barreto, C, De Boeck, K & Ribes-Koninckx, C 2017, 'Innovative approach for self-management and social welfare of children with cystic fibrosis in Europe: Development, validation and implementation of an mHealth tool (MyCyFAPP)', BMJ Open, vol. 7, no. 3, e014931. https://doi.org/10.1136/bmjopen-2016-014931
Calvo-Lerma, Joaquim ; Martinez-Jimenez, Celia P. ; Lázaro-Ramos, Juan Pablo ; Andrés, Ana ; Crespo-Escobar, Paula ; Stav, Erlend ; Schauber, Cornelia ; Pannese, Lucia ; Hulst, Jessie M. ; Suárez, Lucrecia ; Colombo, Carla ; Barreto, Celeste ; De Boeck, Kris ; Ribes-Koninckx, Carmen. / Innovative approach for self-management and social welfare of children with cystic fibrosis in Europe : Development, validation and implementation of an mHealth tool (MyCyFAPP). In: BMJ Open. 2017 ; Vol. 7, No. 3.
@article{440ac33d82ea402ebe5a84317d0595dc,
title = "Innovative approach for self-management and social welfare of children with cystic fibrosis in Europe: Development, validation and implementation of an mHealth tool (MyCyFAPP)",
abstract = "Introduction: For the optimal management of children with cystic fibrosis, there are currently no efficient tools for the precise adjustment of pancreatic enzyme replacement therapy, either for advice on appropriate dietary intake or for achieving an optimal nutrition status. Therefore, we aim to develop a mobile application that ensures a successful nutritional therapy in children with cystic fibrosis. Methods and analysis: A multidisciplinary team of 12 partners coordinate their efforts in 9 work packages that cover the entire so-called 'from laboratory to market' approach by means of an original and innovative co-design process. A cohort of 200 patients with cystic fibrosis aged 1-17 years are enrolled. We will develop an innovative, clinically tested mobile health application for patients and health professionals involved in cystic fibrosis management. The mobile application integrates the research knowledge and innovative tools for maximising self-management with the aim of leading to a better nutritional status, quality of life and disease prognosis. Bringing together different and complementary areas of knowledge is fundamental for tackling complex challenges in disease treatment, such as optimal nutrition and pancreatic enzyme replacement therapy in cystic fibrosis. Patients are expected to benefit the most from the outcomes of this innovative project. Ethics and dissemination: The project is approved by the Ethics Committee of the coordinating organisation, Hospital Universitari La Fe (Ref: 2014/ 0484). Scientific findings will be disseminated via journals and conferences addressed to clinicians, food scientists, information and communications technology experts and patients. The specific dissemination working group within the project will address the wide audience communication through the website (http://www.mycyfapp.eu), the social networks and the newsletter.",
author = "Joaquim Calvo-Lerma and Martinez-Jimenez, {Celia P.} and L{\'a}zaro-Ramos, {Juan Pablo} and Ana Andr{\'e}s and Paula Crespo-Escobar and Erlend Stav and Cornelia Schauber and Lucia Pannese and Hulst, {Jessie M.} and Lucrecia Su{\'a}rez and Carla Colombo and Celeste Barreto and {De Boeck}, Kris and Carmen Ribes-Koninckx",
year = "2017",
month = "3",
day = "1",
doi = "10.1136/bmjopen-2016-014931",
language = "English",
volume = "7",
journal = "BMJ Open",
issn = "2044-6055",
publisher = "BMJ Publishing Group",
number = "3",

}

TY - JOUR

T1 - Innovative approach for self-management and social welfare of children with cystic fibrosis in Europe

T2 - Development, validation and implementation of an mHealth tool (MyCyFAPP)

AU - Calvo-Lerma, Joaquim

AU - Martinez-Jimenez, Celia P.

AU - Lázaro-Ramos, Juan Pablo

AU - Andrés, Ana

AU - Crespo-Escobar, Paula

AU - Stav, Erlend

AU - Schauber, Cornelia

AU - Pannese, Lucia

AU - Hulst, Jessie M.

AU - Suárez, Lucrecia

AU - Colombo, Carla

AU - Barreto, Celeste

AU - De Boeck, Kris

AU - Ribes-Koninckx, Carmen

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Introduction: For the optimal management of children with cystic fibrosis, there are currently no efficient tools for the precise adjustment of pancreatic enzyme replacement therapy, either for advice on appropriate dietary intake or for achieving an optimal nutrition status. Therefore, we aim to develop a mobile application that ensures a successful nutritional therapy in children with cystic fibrosis. Methods and analysis: A multidisciplinary team of 12 partners coordinate their efforts in 9 work packages that cover the entire so-called 'from laboratory to market' approach by means of an original and innovative co-design process. A cohort of 200 patients with cystic fibrosis aged 1-17 years are enrolled. We will develop an innovative, clinically tested mobile health application for patients and health professionals involved in cystic fibrosis management. The mobile application integrates the research knowledge and innovative tools for maximising self-management with the aim of leading to a better nutritional status, quality of life and disease prognosis. Bringing together different and complementary areas of knowledge is fundamental for tackling complex challenges in disease treatment, such as optimal nutrition and pancreatic enzyme replacement therapy in cystic fibrosis. Patients are expected to benefit the most from the outcomes of this innovative project. Ethics and dissemination: The project is approved by the Ethics Committee of the coordinating organisation, Hospital Universitari La Fe (Ref: 2014/ 0484). Scientific findings will be disseminated via journals and conferences addressed to clinicians, food scientists, information and communications technology experts and patients. The specific dissemination working group within the project will address the wide audience communication through the website (http://www.mycyfapp.eu), the social networks and the newsletter.

AB - Introduction: For the optimal management of children with cystic fibrosis, there are currently no efficient tools for the precise adjustment of pancreatic enzyme replacement therapy, either for advice on appropriate dietary intake or for achieving an optimal nutrition status. Therefore, we aim to develop a mobile application that ensures a successful nutritional therapy in children with cystic fibrosis. Methods and analysis: A multidisciplinary team of 12 partners coordinate their efforts in 9 work packages that cover the entire so-called 'from laboratory to market' approach by means of an original and innovative co-design process. A cohort of 200 patients with cystic fibrosis aged 1-17 years are enrolled. We will develop an innovative, clinically tested mobile health application for patients and health professionals involved in cystic fibrosis management. The mobile application integrates the research knowledge and innovative tools for maximising self-management with the aim of leading to a better nutritional status, quality of life and disease prognosis. Bringing together different and complementary areas of knowledge is fundamental for tackling complex challenges in disease treatment, such as optimal nutrition and pancreatic enzyme replacement therapy in cystic fibrosis. Patients are expected to benefit the most from the outcomes of this innovative project. Ethics and dissemination: The project is approved by the Ethics Committee of the coordinating organisation, Hospital Universitari La Fe (Ref: 2014/ 0484). Scientific findings will be disseminated via journals and conferences addressed to clinicians, food scientists, information and communications technology experts and patients. The specific dissemination working group within the project will address the wide audience communication through the website (http://www.mycyfapp.eu), the social networks and the newsletter.

UR - http://www.scopus.com/inward/record.url?scp=85015733435&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015733435&partnerID=8YFLogxK

U2 - 10.1136/bmjopen-2016-014931

DO - 10.1136/bmjopen-2016-014931

M3 - Article

AN - SCOPUS:85015733435

VL - 7

JO - BMJ Open

JF - BMJ Open

SN - 2044-6055

IS - 3

M1 - e014931

ER -